Breaking News
1 day ago
Simantini Singh Deo
Dianthus appoints biotech veteran Dr. Simon Read to Board as Lonnie Moulder steps down.
Simantini Singh Deo
Roche’s Susvimo receives FDA approval as the first continuous delivery treatment for diabetic retinopathy.
Simantini Singh Deo
PacBio partners with Haorui Gene to expand HiFi long-read sequencing for clinical genomics in China.
Simantini Singh Deo
Astellas and Pfizer's XTANDI shows 5-year survival benefit with 30% reduced death risk in prostate cancer trials.
Vaibhavi M.